Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sasidharan Padmaja Divya

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|March 24, 2017
Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cellsYoung-Ok Son, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
The Journal of Biological Chemistry|October 7, 2018
Withdrawal: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cellsYoung-Ok Son, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
Scientific Reports|November 16, 2019
Retraction Note: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanismPoyil Pratheeshkumar, Young-Ok Son, Sasidharan Padmaja Divya, et al.
Scientific Reports|November 24, 2016
Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanismPoyil Pratheeshkumar, Young-Ok Son, Sasidharan Padmaja Divya, et al.
Toxicology and Applied Pharmacology|July 30, 2016
Different roles of ROS and Nrf2 in Cr(VI)-induced inflammatory responses in normal and Cr(VI)-transformed cellsRam Vinod Roy, Poyil Pratheeshkumar, Yong-Ok Son, et al.
Cancers|February 4, 2021
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by <i>BRAFV600E</i> MutationAbdul K Siraj, Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, et al.
Oncotarget|January 17, 2019
Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatmentAbdul Khalid Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, et al.
International Journal of Molecular Sciences|January 9, 2021
CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC CellsPoyil Pratheeshkumar, Abdul K Siraj, Sasidharan Padmaja Divya, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 10, 2015
Epigenetic targets of arsenic: emphasis on epigenetic modifications during carcinogenesisRam Vinod Roy, Young-Ok Son, Poyil Pratheeshkumar, et al.
The Journal of Biological Chemistry|October 7, 2018
Withdrawal: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesisYoung-Ok Son, Poyil Pratheeshkumar, Ram Vinod Roy, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|March 24, 2017
Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cellsYoung-Ok Son, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
The Journal of Biological Chemistry|October 7, 2018
Withdrawal: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cellsYoung-Ok Son, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
Scientific Reports|November 16, 2019
Retraction Note: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanismPoyil Pratheeshkumar, Young-Ok Son, Sasidharan Padmaja Divya, et al.
Scientific Reports|November 24, 2016
Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanismPoyil Pratheeshkumar, Young-Ok Son, Sasidharan Padmaja Divya, et al.
Toxicology and Applied Pharmacology|July 30, 2016
Different roles of ROS and Nrf2 in Cr(VI)-induced inflammatory responses in normal and Cr(VI)-transformed cellsRam Vinod Roy, Poyil Pratheeshkumar, Yong-Ok Son, et al.
Cancers|February 4, 2021
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by <i>BRAFV600E</i> MutationAbdul K Siraj, Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, et al.
Oncotarget|January 17, 2019
Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatmentAbdul Khalid Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, et al.
International Journal of Molecular Sciences|January 9, 2021
CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC CellsPoyil Pratheeshkumar, Abdul K Siraj, Sasidharan Padmaja Divya, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 10, 2015
Epigenetic targets of arsenic: emphasis on epigenetic modifications during carcinogenesisRam Vinod Roy, Young-Ok Son, Poyil Pratheeshkumar, et al.
The Journal of Biological Chemistry|October 7, 2018
Withdrawal: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesisYoung-Ok Son, Poyil Pratheeshkumar, Ram Vinod Roy, et al.
Pageof 3